Marcus price target raised to $23 from $22 at Wedbush

Wedbush raised the firm’s price target on Marcus (MCS) to $23 from $22 and keeps an Outperform rating on the shares. The firm has a positive bias, as Marcus is poised to benefit from a more consistent theatrical release slate over the next several quarters; is likely to raise the dividend back toward pre-pandemic rates, repurchase shares, and/or locate accretive M&A in both theaters and hotels, with no significant debt maturities until 2027; and owns most of its properties with room to monetize surplus real estate.